Showing results (61-70 of 1,545) with videos related to

Sort By:
Pageof 155
Leukemia Research|November 1, 1996
Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in miceS Singhal, U Vourka-Karussis, J Mehta, et al.
Bailliere'S Clinical Haematology|July 1, 1991
Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantationS Slavin, A Ackerstein, U Vourka-Karussis, et al.
American Journal of Clinical Oncology|August 1, 1997
Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patientsR Ben-Yosef, R Or, E Naparstek, et al.
British Journal of Haematology|January 1, 1995
The response of cord blood megakaryocyte progenitors to IL-3, IL-6 and aplastic canine serum varies with gestational ageV R Deutsch, T A Olson, A Nagler, et al.
Cancer Genetics and Cytogenetics|August 1, 1994
Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridizationA Amiel, S Yarkoni, S Slavin, et al.
Bone Marrow Transplantation|October 1, 1992
Successful T cell-depleted allogeneic bone marrow transplantation in a child with recurrent multiple extramedullary plasmacytomasR Or, J Mehta, E Naparstek, et al.
Hepatology (Baltimore, Md.)|August 1, 1993
Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantationY Ilan, A Nagler, R Adler, et al.
Acta Haematologica|October 30, 1998
Continuous interleukin-2 infusion combined with cyclophosphamide- based combination chemotherapy in the treatment of hemato-oncological malignancies. Results of a phase I-II studyA Nagler, A Ackerstein, M Ben-Shahar, et al.
Blood|March 15, 1996
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantationS Slavin, E Naparstek, A Nagler, et al.
Clinical and Experimental Immunology|August 1, 1994
Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donorsY Ilan, A Nagler, D Shouval, et al.
Pageof 155